Predicted to enable nucleotidyltransferase activity. Is an ortholog of C. elegans gld-2. In C. elegans, gld-2 is involved in several processes, including nucleus organization; positive regulation of meiosis I; and regulation of cell division.
Predicted to enable RNA binding activity. Is an ortholog of C. elegans gld-1. In C. elegans, gld-1 is involved in negative regulation of nitrogen compound metabolic process; oocyte fate determination; and regulation of reproductive process.
Is predicted to encode a protein with the following domains: 14-3-3 domain superfamily; 14-3-3 domain; and 14-3-3 protein. Is an ortholog of C. elegans M117.3; ftt-2; and par-5. In C. elegans, ftt-2 is involved in cytoplasmic sequestering of protein; dauer larval development; and negative regulation of protein import into nucleus.
Is predicted to encode a protein with the following domains: 14-3-3 domain superfamily; 14-3-3 domain; and 14-3-3 protein. Is an ortholog of C. elegans M117.3; ftt-2; and par-5. In C. elegans, ftt-2 is involved in cytoplasmic sequestering of protein; dauer larval development; and negative regulation of protein import into nucleus.
Predicted to enable calcium ion binding activity and glycerol-3-phosphate dehydrogenase (quinone) activity. Predicted to be involved in glycerol-3-phosphate metabolic process. Predicted to be part of glycerol-3-phosphate dehydrogenase complex. Is an ortholog of C. elegans gpdh-3.
Is affected by 20-hydroxyecdysone based on proteomic studies. Is predicted to encode a protein with the following domains: Integrator complex subunit 3, N-terminal; Integrator complex subunit 3 N-terminal; and Integrator complex subunit 3. Is an ortholog of C. elegans ints-3.
Is predicted to encode a protein with the following domains: Resistance to inhibitors of cholinesterase protein 3; Resistance to inhibitors of cholinesterase protein 3, N-terminal; and Resistance to inhibitors of cholinesterase homologue 3.